Neurosense Therapeutics is trading at $2.33, down 9.12%, amid a sharply lower broader market. - The price was recorded at 10:50 a.m. EST on October 22, 2026. - No company-specific announcement dated October 22 was found, and a market listing showed no headlines for that date. - The Nasdaq and S&P 500 were sharply lower amid geopolitical tensions and concerns about technology spending. This risk-off backdrop is the most plausible context for the decline, though no source directly attributed the stock’s move to it.